News
AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move ...
NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in ...
(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...
Virtual. About Innate Pharma. Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunothera ...
Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior day's close.
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Explore more
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...
AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...
Scientists from the University of Sheffield and AstraZeneca have created an AI approach that could make designing proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results